1. Shimizu, Mikito, Shiraishi, Naoyuki, Tada, Satoru, Okuno, Tatsusada, Mochizuki, Hideki. 2023. RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS. In Science advances, 9, eadg3193. doi:10.1126/sciadv.adg3193. https://pubmed.ncbi.nlm.nih.gov/37992159/
2. Iwamoto, Shosuke, Itokazu, Takahide, Sasaki, Atsushi, Fujihara, Kazuo, Yamashita, Toshihide. 2022. RGMa Signal in Macrophages Induces Neutrophil-Related Astrocytopathy in NMO. In Annals of neurology, 91, 532-547. doi:10.1002/ana.26327. https://pubmed.ncbi.nlm.nih.gov/35167145/
3. Wang, Zijie, Zhang, Shaoru, Cheng, Ruiqi, Jiang, Anan, Qin, Xinyue. 2024. Knockdown of RGMA improves ischemic stroke via Reprogramming of Neuronal Metabolism. In Free radical biology & medicine, 218, 41-56. doi:10.1016/j.freeradbiomed.2024.03.020. https://pubmed.ncbi.nlm.nih.gov/38556067/
4. Li, Yan, Liu, Hai-Ting, Chen, Xu, Zou, Yong-Xin, Gao, Peng. 2021. Aberrant promoter hypermethylation inhibits RGMA expression and contributes to tumor progression in breast cancer. In Oncogene, 41, 361-371. doi:10.1038/s41388-021-02083-y. https://pubmed.ncbi.nlm.nih.gov/34754080/
5. Song, Fengliang, Yang, Zhao, Li, Liang, Zhang, Baohua, Wang, Hongyang. . MiR-552-3p promotes malignant progression of gallbladder carcinoma by reactivating the Akt/β-catenin signaling pathway due to inhibition of the tumor suppressor gene RGMA. In Annals of translational medicine, 9, 1374. doi:10.21037/atm-21-2013. https://pubmed.ncbi.nlm.nih.gov/34733926/
6. Phan, Thi Le, Kim, Hyun-Jin, Lee, Suk Jun, Choi, Moon-Chang, Kim, Sung-Hak. 2021. Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma. In OncoTargets and therapy, 14, 4867-4878. doi:10.2147/OTT.S317285. https://pubmed.ncbi.nlm.nih.gov/34588781/